Article

CD52 is a prognostic biomarker and correlated with immune features in breast cancer

2020-06-02

Abstract excerpt

<h4>Background: </h4> Breast cancer (BRCA) is the most commonly diagnosed cancer of women, which is aggressive cancer and has a mortality rate. CD52 and its monoclonal antibody (Alemtuzumab) play a critical role in inflammatory diseases, but the relationship between CD52 and BRCA is not clear. <h4>Methods: </h4>: We first used the random forest algorithm to find the most critical genes related to the prognosis of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9fb5da29-ec1d-5c5c-a54e-c2081033af45
DOI: 10.21203/rs.3.rs-31586/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CD52 is a prognostic biomarker and correlated with immune features in breast cancerDOI 10.21203/rs.3.rs-31586/v1Read

Comprehensive Analysis of the Immune Microenvironment Reveals that CD52 is a Marker for Breast Cancer Treatment with Immune Checkpoint InhibitorsSemantic proximity Read

TPD52 as a Therapeutic Target Identified by Machine Learning Shapes the Immune Microenvironment in Breast CancerSemantic proximity Read

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor MicroenvironmentSemantic proximity Read

The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancerSemantic proximity Read

ADRB2 is a potential protective gene in breast cancer by regulating tumor immune microenvironmentSemantic proximity Read

Integrated transcriptome and single-cell sequencing reveals M2-like tumor-associated macrophages-related prognostic signatures in breast cancerSemantic proximity Read

Identification of the new molecular subtypes related to inflammation in breast cancer.Semantic proximity Read

TPD52 promotes breast cancer cell migration, invasion and proliferation via activation of the MAPK/ERK signaling pathwaySemantic proximity Read

CXCL2 as a Prognostic Marker in Breast Cancer is Associated with Immune Infiltration and Regulated by miR-215Semantic proximity Read

Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.Semantic proximity Read

CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancerSemantic proximity Read

Unveiling the key mechanisms of FOLR2+ macrophage-mediated antitumor immunity in breast cancer using integrated single-cell RNA sequencing and bulk RNA sequencingSemantic proximity Read